Arcas can achieve unmatched translatability of oncology drug screens in the early development phase, leading to a more efficient and cheaper drug development process.
Read More
More informative molecular cancer subtypes can be obtained using deep learning and multi-omics.
Read More
Arcas technology helping with drug development and cancer research.
Read More